Advertisement

Vitamin D pp 453-467 | Cite as

Vitamin D Deficiency and Consequences for the Health of People in Mediterranean Countries

Chapter
  • 3.7k Downloads
Part of the Nutrition and Health book series (NH)

Abstract

The results of several recent cross-sectional observational studies conducted across Spain and other Mediterranean countries showed a very high prevalence of population with vitamin D deficiency, which produces skeletal and extra skeletal health consequences for the Mediterranean populations. According to these data it is important to highlight the need for improving patient’s and physician’s understanding of the optimization of vitamin D status irrespective of the hypothetical availability of hours of sun in Mediterranean countries. The medical community has an ethical responsibility to heighten efforts by individual health surveillance to ensure adequate vitamin D intake by patients and to teach the public about vitamin D.

Governmental policy and health policy makers will have to decide whether food fortification or supplements are the best way to achieve adequate vitamin D levels in Mediterranean populations.

KeyWords

Spain mediterranean countries 25-hydroxyvitamin D vitamin D deficiency North Africa UV sunlight vitamin D infants clothing 

References

  1. 1.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281PubMedCrossRefGoogle Scholar
  2. 2.
    Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501PubMedCrossRefGoogle Scholar
  3. 3.
    Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al (2004) Effect of Vitamin D on falls: a meta-analysis. JAMA 291:1999–2006PubMedCrossRefGoogle Scholar
  4. 4.
    Quesada Gómez JM, Alonso J, Bouillon R (1996) Vitamin D insufficiency as a determinant of hip fractures. Osteoporos Int 6(Suppl 3):42–47CrossRefGoogle Scholar
  5. 5.
    Bischoff-Ferrari HA, Giovannucci E, Willett WC (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMedGoogle Scholar
  6. 6.
    Bouillon R, Bischoff-Ferrari H, Willett W (2008) Vitamin D and health: perspectives from mice and man. J Bone Miner Res 23:974–979PubMedCrossRefGoogle Scholar
  7. 7.
    Holick MF, Biancuzzo RM, Chen TC et al. (2008) Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93:677–681PubMedCrossRefGoogle Scholar
  8. 8.
    Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride/Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food, and Nutrition Board, Institute of Medicine. National Academy Press, Washington, DCGoogle Scholar
  9. 9.
    Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289:F8–F28PubMedCrossRefGoogle Scholar
  10. 10.
    Lips P, Chapuy MC, Dawson-Hughes B et al (1999) An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 11:394–397CrossRefGoogle Scholar
  11. 11.
    Lensmeyer GL, Wiebe DA, Binkley N et al (2006) HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52:1120–1126PubMedCrossRefGoogle Scholar
  12. 12.
    Dawson-Hughes B, Heaney RP, Holick MF et al (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716PubMedCrossRefGoogle Scholar
  13. 13.
    Roux C, Bischoff-Ferrari HA, Papapoulos SE et al (2008) New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. Curr Med Res Opin 24:1363–1370PubMedCrossRefGoogle Scholar
  14. 14.
    Mata-Granados JM, Luque de Castro MD, Quesada Gomez JM (2008) Inappropriate serum levels of retinol, alpha-tocopherol, 25 hydroxyvitamin D3 and 24,25 dihydroxyvitamin D3 levels in healthy Spanish adults: simultaneous assessment by HPLC. Clin Biochem 4:676–680CrossRefGoogle Scholar
  15. 15.
    Barger-Lux MJ, Heaney RP (2002) Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87:4952–4956PubMedCrossRefGoogle Scholar
  16. 16.
    McKenna MJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69–77PubMedCrossRefGoogle Scholar
  17. 17.
    vd Wielen RPJ, Lowik MRH, vd Berg H et al (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346:207–210CrossRefGoogle Scholar
  18. 18.
    Lips P, Duong T, Oleksik AM et al for the MORE Study Group (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86:1212–1221PubMedCrossRefGoogle Scholar
  19. 19.
    Lips P, Hosking D, Lippuner K et al (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260:245–254PubMedCrossRefGoogle Scholar
  20. 20.
    Chapuy MC, Schott AM, Garnero P et al (1996) Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81:1129–1133PubMedCrossRefGoogle Scholar
  21. 21.
    Chapuy MC, Preziosi P, Maamer M et al (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439–443PubMedCrossRefGoogle Scholar
  22. 22.
    Bettica P, Bevilacqua M, Vago T et al (1999) High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in Northern Italy for initial screening. Osteoporos Int 9:226–229PubMedCrossRefGoogle Scholar
  23. 23.
    Isaia G, Giorgino R, Rini GB et al (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 14:577–582PubMedCrossRefGoogle Scholar
  24. 24.
    Cigolini M, Miconi V, Soffiati G et al (2006) Hipovitaminosis D among unselected medical inpatients and outpatients in Northern Italy. Clin Endocrinol (Oxf) 64:475CrossRefGoogle Scholar
  25. 25.
    Papapetrou PD, Triantaphyllopoulou M, Karga H et al (2007) Vitamin D deficiency in the elderly in Athens, Greece. J Bone Miner Metab 25:198–203PubMedCrossRefGoogle Scholar
  26. 26.
    Lapatsanis D, Moules A, Cholevas V (2005) Vitamin D: a necessity for children and adolescents in Greece Calcif. Tissue Int 77:348–355CrossRefGoogle Scholar
  27. 27.
    Quesada JM, Jans I, Benito P et al (1989) Vitamin D status of elderly people in Spain. Age Ageing 18:392–397PubMedCrossRefGoogle Scholar
  28. 28.
    Quesada JM, Coopmans W, Ruiz P (1992) Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 75:494–501PubMedCrossRefGoogle Scholar
  29. 29.
    Mata-Granados JM, Luque de Castro MD, Quesada JM (2008) Inappropriate serum levels of retinol, α-tocopherol, 25 hydroxyvitamin D3 and 24,25 dihydroxy vitamin D3 levels in healthy Spanish adults: Simultaneous assessment by HPLC. Clin Biochem 41:676–680PubMedCrossRefGoogle Scholar
  30. 30.
    Mezquita-Raya P, Muñoz-Torres M, Luna JD et al (2001) Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res 16:1408–1415PubMedCrossRefGoogle Scholar
  31. 31.
    Aguado P, del Campo MT, Garces M et al (2000) Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 11:739–744PubMedCrossRefGoogle Scholar
  32. 32.
    Larrosa M, Gratacòs J, Vaqueiro M et al (2001) Prevalencia de hipovitaminosis D en una población anciana institucionalizada. Valoración del tratamiento sustitutivo. Med Clin (Barc) 117:611–614Google Scholar
  33. 33.
    Vaqueiro M, Baré ML, Anton E (2006) Valoración del umbral óptimo de vitamina D en la población mayor de 64 años. Med Clin (Barc). 127:648–650CrossRefGoogle Scholar
  34. 34.
    González-Clemente JM, Martínez-Osaba MJ, Miñarro A et al (1999) Hipovitaminosis D: alta prevalencia en ancianos de Barcelona atendidos ambulatoriamente. Factores asociados. Med Clin (Barc) 113:641–645Google Scholar
  35. 35.
    Gómez-Alonso C, Naves-Díaz ML, Fernández-Martín JL et al (2003) Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 63:S44–S48CrossRefGoogle Scholar
  36. 36.
    Pérez-Llamas F, López-Contreras MJ, Blanco MJ et al (2008) Seemingly paradoxical seasonal influences on vitamin D status in nursing-home elderly people from a Mediterranean area. Nutrition 24:414–420PubMedCrossRefGoogle Scholar
  37. 37.
    Docio S, Riancho JA, Pérez A et al (1998) Seasonal deficiency of vitamin D in children: A potential target for osteoporosis-preventing strategies?. J Bone Miner Res 13:544–548PubMedCrossRefGoogle Scholar
  38. 38.
    Perez Castrillón JL, Niño Martin V (2008) Niveles de vitamina D en población mayor de 65 años. REEMO. 17:1–4Google Scholar
  39. 39.
    Quesada Gomez JM, Mata Granados JM, Delgadillo J et al (2007) Low calcium intake and insufficient serum vitamin D status in treated and non-treated postmenopausal osteoporotic women in Spain. J Bone Miner Metab 22:S309Google Scholar
  40. 40.
    Binkley N, Krueger D, Cowgill C et al (2003) Assay variation confounds hypovitaminosis D diagnosis: a call for standardization. J Clin Endocrinol Metab 89:3152–3157CrossRefGoogle Scholar
  41. 41.
    Binkley N, Krueger D, Gemar D (2008) Correlation among 25-Hydroxy-Vitamin D Assays. J Clin Endocrinol Metab 89:3152–3157CrossRefGoogle Scholar
  42. 42.
    Carter GD, Carter R, Jones JJB (2004) How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D External Quality Assessment Scheme. Clin Chem 50:2195–2197PubMedCrossRefGoogle Scholar
  43. 43.
    Brustad M, Sandanger T, Aksnes L (2004) Vitamin D status in a rural population of northern Norway with high fish liver consumption. Public Health Nutr 7:783–789PubMedGoogle Scholar
  44. 44.
    Holick MF, Siris ES, Binkley N et al. (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215–3224PubMedCrossRefGoogle Scholar
  45. 45.
    Lips P (2007) Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 103:620–625PubMedCrossRefGoogle Scholar
  46. 46.
    Maalouf G, Gannagé-Yared MH, Ezzedine J et al (2007) Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact 7:131–143PubMedGoogle Scholar
  47. 47.
    Alagol F, Shihadeh Y, Boztepe H (2000) Sunlight exposure and vitamin D deficiency in Turkish women. J Endocrinol Invest 23:173–177PubMedGoogle Scholar
  48. 48.
    Atli T, Gullu S, Uysal AR et al (2005) The prevalence of vitamin D deficiency and effects of ultraviolet light on vitamin D levels in elderly Turkish population, Arch. Gerontol Geriatr 40:53–60CrossRefGoogle Scholar
  49. 49.
    Guzel R, Kozanoglu E, Guler-Uysal F et al (2001) Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend Based Med 10:765–770PubMedCrossRefGoogle Scholar
  50. 50.
    Gannage-Yared MH, Chemali R, Yaacoub N et al (2000) Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 15:1856–1862PubMedCrossRefGoogle Scholar
  51. 51.
    El-Hajj Fuleihan G, Nabulsi M, Choucair M et al (2001) Hypovitaminosis D in healthy schoolchildren. Pediatrics 107:E53PubMedCrossRefGoogle Scholar
  52. 52.
    Gannagé-Yared MH, Maalouf G, Khalife S et al (2008) Prevalence and predictors of vitamin D inadequacy amongst Lebanese osteoporotic women. Br J Nutr 17:1–5Google Scholar
  53. 53.
    Goldray D, Mizrahi-Sasson E,, Merdler C et al (1989) Vitamin D deficiency in elderly patients in a general hospital. J Am Geriatr Soc 37:589–592PubMedGoogle Scholar
  54. 54.
    Meddeb N, Sahli H, Chahed M et al (2005) Vitamin D deficiency in Tunisia. Osteopor Int 16:180–183CrossRefGoogle Scholar
  55. 55.
    Allali F, El Aichaoui S, Khazani H et al (2009) High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density. Semin Arthritis Rheum 38:444–451Google Scholar
  56. 56.
    Holick MF (2006) High prevalence of Vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373PubMedCrossRefGoogle Scholar
  57. 57.
    Yeste D, Carrascosa A on behalf of Grupo Interhospitalario para el Estudio del raquitismo Carencial en Cataluña (GIERCC) (2003) Raquitismo carencial en la infancia: análisis de 62 casos. Med Clin (Barc) 121:23–27CrossRefGoogle Scholar
  58. 58.
    Kanis JA, Burlet N, Cooper C et al (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399–428PubMedCrossRefGoogle Scholar
  59. 59.
    Giovannucci E, Liu Y, Hollis BW et al (2008) Independent Association of Low Serum 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 168:1174–1180PubMedCrossRefGoogle Scholar
  60. 60.
    Dobnig H, Pilz S, Scharnagl H et al (2008) 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340–1349PubMedCrossRefGoogle Scholar
  61. 61.
    Adit A, Ginde AA, Scragg R, et al (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. Adults. J Am Geriatr Soc 57: 1595–1603Google Scholar
  62. 62.
    Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials Arch Intern Med 167:1730–1737PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Unidad de Metabolismo Mineral, Servicio de Endocrinología y Nutrición, Centro CEDOS y Unidad de I+D+i SanyresHospital Universitário Reina Sofia, RETICEFCórdobaSpain
  2. 2.Metabolic Bone Diseases Unit, Fundación Jiménez DíazMedicine Chair Metabolic Bone Diseases Universidad Autonoma, RETICEFMadridSpain

Personalised recommendations